96 results
Page 2 of 5
6-K
EX-99.1
nr3o0yglsv6
29 Nov 23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
7:00am
6-K
EX-99.1
cb4oa1
13 Nov 23
STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
6:15am
F-3
EX-5.1
y06fy7 pn9mjxvo
20 Oct 23
Shelf registration (foreign)
4:06pm
F-3
EX-4.5
ga6w6hg7189ed5
20 Oct 23
Shelf registration (foreign)
4:06pm
F-3
s9kwrst
20 Oct 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.1
0shcm82
21 Sep 23
Current report (foreign)
7:59am
6-K
EX-99.1
hoxjwa 1axis7
5 Sep 23
Alvotech Announces Changes to the Leadership Team
4:51pm
6-K
EX-99.6
na8zf c3d
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.5
nesqtko
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.8
j3f40ql2om0 z2inzn67
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.3
p4owrm1
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.1
dmcn d3k1tgt8o5
1 Aug 23
Alvotech Completes $100 Million
8:00am
6-K
EX-99.1
45v1oe6b8paq s7g
24 Jul 23
Provide Update on Strategic Biosimilars Partnership
4:15pm
6-K
EX-99.2
q4jztyrb6cp 5a
24 Jul 23
Provide Update on Strategic Biosimilars Partnership
4:15pm
6-K
EX-5.1
w3x7 hi1u30rtujfczfu
24 Jul 23
Provide Update on Strategic Biosimilars Partnership
4:15pm
F-3
EX-5.1
ybeqws6h1ifdn370dl
14 Jul 23
Shelf registration (foreign)
4:56pm
6-K
EX-99.4
rmhrq9suwb4ux
12 Jul 23
This Termination Agreement (“Termination Agreement”) by
12:00am
424B3
9p20h0pv8i12kr7
29 Jun 23
Prospectus supplement
7:38am
6-K
EX-99.1
bs9q 89viex
29 Jun 23
Alvotech Provides Regulatory Update
7:35am
6-K
EX-99.1
46rcoqe7
13 Jun 23
Current report (foreign)
8:12am